
Metisox Ltd is an innovative technology company specializing in artificial intelligence and machine learning solutions, expert services, and custom databases and software for researchers and decision-makers in the pharmaceutical, chemical, nutrition, and agrochemical industries. The company offers a range of products including RNA-Seq Data Analysis, Target Safety Assessment, Scientific Data Curation, Bioinformatics Analysis, SysWiz Database, Biomarker Discovery, and Carcinogenicity Risk Assessment. Metisox has a strong scientific foundation with a core management team possessing over 150 person years of pharmaceutical and industrial R&D experience and nearly 200 person years of expert curated content for proprietary databases. The company ensures high quality assurance by adhering to strict ISO norms. Its Biomarker Discovery product includes the Sabida database, a manually curated resource with over 5,000 unique genes and 2,000 toxicity gene signatures, supporting patient stratification and biomarker identification for clinical scientists and industries such as pharmaceuticals, food/agrochemical, and chemical sectors.

Metisox Ltd is an innovative technology company specializing in artificial intelligence and machine learning solutions, expert services, and custom databases and software for researchers and decision-makers in the pharmaceutical, chemical, nutrition, and agrochemical industries. The company offers a range of products including RNA-Seq Data Analysis, Target Safety Assessment, Scientific Data Curation, Bioinformatics Analysis, SysWiz Database, Biomarker Discovery, and Carcinogenicity Risk Assessment. Metisox has a strong scientific foundation with a core management team possessing over 150 person years of pharmaceutical and industrial R&D experience and nearly 200 person years of expert curated content for proprietary databases. The company ensures high quality assurance by adhering to strict ISO norms. Its Biomarker Discovery product includes the Sabida database, a manually curated resource with over 5,000 unique genes and 2,000 toxicity gene signatures, supporting patient stratification and biomarker identification for clinical scientists and industries such as pharmaceuticals, food/agrochemical, and chemical sectors.